| Product Code: ETC9961516 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States saw a significant decline in CIS insulin import shipments with a negative CAGR of -31.87% from 2020 to 2024 and a sharp growth rate decrease of -39.06% from 2023 to 2024. Despite the top exporting countries being Austria, Metropolitan France, Italy, Germany, and Brazil, the Herfindahl-Hirschman Index (HHI) indicated very low concentration in the market. This data suggests a challenging landscape for insulin imports into the US, signaling potential shifts in market dynamics or regulatory changes impacting the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) CIS Insulin Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) CIS Insulin Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) CIS Insulin Market - Industry Life Cycle |
3.4 United States (US) CIS Insulin Market - Porter's Five Forces |
3.5 United States (US) CIS Insulin Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.6 United States (US) CIS Insulin Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.7 United States (US) CIS Insulin Market Revenues & Volume Share, By Source, 2022 & 2032F |
4 United States (US) CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the US |
4.2.2 Technological advancements in insulin delivery systems |
4.2.3 Growing awareness about the benefits of early insulin therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin products |
4.3.2 High cost associated with insulin therapy |
4.3.3 Potential side effects and risks associated with insulin use |
5 United States (US) CIS Insulin Market Trends |
6 United States (US) CIS Insulin Market, By Types |
6.1 United States (US) CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) CIS Insulin Market Revenues & Volume, By Application, 2022 - 2032F |
6.1.3 United States (US) CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2022 - 2032F |
6.1.4 United States (US) CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2022 - 2032F |
6.2 United States (US) CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) CIS Insulin Market Revenues & Volume, By Rapid Acting, 2022 - 2032F |
6.2.3 United States (US) CIS Insulin Market Revenues & Volume, By Long Acting, 2022 - 2032F |
6.2.4 United States (US) CIS Insulin Market Revenues & Volume, By Short Acting, 2022 - 2032F |
6.2.5 United States (US) CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2022 - 2032F |
6.2.6 United States (US) CIS Insulin Market Revenues & Volume, By Premixed, 2022 - 2032F |
6.3 United States (US) CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 United States (US) CIS Insulin Market Revenues & Volume, By Analog, 2022 - 2032F |
6.3.3 United States (US) CIS Insulin Market Revenues & Volume, By Human Recombinant, 2022 - 2032F |
7 United States (US) CIS Insulin Market Import-Export Trade Statistics |
7.1 United States (US) CIS Insulin Market Export to Major Countries |
7.2 United States (US) CIS Insulin Market Imports from Major Countries |
8 United States (US) CIS Insulin Market Key Performance Indicators |
8.1 Average age of diabetes diagnosis in the US |
8.2 Adoption rate of new insulin delivery technologies |
8.3 Number of diabetes education programs conducted annually |
8.4 Percentage of diabetic patients with controlled blood sugar levels |
8.5 Rate of hospital admissions due to diabetes-related complications |
9 United States (US) CIS Insulin Market - Opportunity Assessment |
9.1 United States (US) CIS Insulin Market Opportunity Assessment, By Application, 2022 & 2032F |
9.2 United States (US) CIS Insulin Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.3 United States (US) CIS Insulin Market Opportunity Assessment, By Source, 2022 & 2032F |
10 United States (US) CIS Insulin Market - Competitive Landscape |
10.1 United States (US) CIS Insulin Market Revenue Share, By Companies, 2025 |
10.2 United States (US) CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here